A phase 1/2 study of metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer

Vincent Picozzi, Vaibhav Sahai, Diane Simeone, Caio Rocha Lima, Allyson Ocean, Philip Philip, Wasif Saif, Aparna Kalyan, Michael Ondovik, Jack Shiansong Li, Chrystal Louis

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)iii81-iii82
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Jun 1 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this